Class II · Moderate risk Ongoing
Blemish Spot Treatment
Reason Failed Stability Specifications
Acne Treatment Pads
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Subpotent drug: The product active ingredient level not matching the exact levels indicated on the packaging label.
What was recalled
Acne Treatment Pads (2% salicylic acid), packaged in a 50-count jar, OTC, Distributed by: Greenbrier International, Inc. 500 Volvo Parkway, Chesapeake, VA 23320, NDC 71537-001-02
- Recalling firm
- Huijing (Shanghai) Bio-tech Co., Ltd.
- NDC code
- 71537-001-02
- Origin
- China
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1076-2018
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Salicylic recalls
See all
Class II · Moderate risk Terminated
Kingskin
Reason CGMP Deviations
Class II · Moderate risk Ongoing
La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System
Reason cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.
Class II · Moderate risk Terminated
Blemfree All Day Lotion
Reason CGMP Deviations: Manufactured without following Current Good Manufacturing Practises.
Class II · Moderate risk Completed
Gordofilm Wart Remover
Reason cGMP Deviations
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.